share_log

4: Statement of changes in beneficial ownership of securities-Director Loewy Caroline M

4: Statement of changes in beneficial ownership of securities-Director Loewy Caroline M

4:持股变动声明-董事 Loewy Caroline M
美股SEC公告 ·  06/13 18:49

Moomoo AI 已提取核心信息

Caroline M. Loewy, associated with eFFECTOR Therapeutics, Inc. (EFTR), has been involved in a transaction dated 06/13/2024. Specific details regarding the nature of the transaction, including the number of shares, transaction price, and total value, have not been disclosed. The relationship of Loewy to the issuer was not specified in the announcement. Without these details, the impact of the transaction on Loewy's holdings and the overall market position of eFFECTOR Therapeutics remains unclear.
Caroline M. Loewy, associated with eFFECTOR Therapeutics, Inc. (EFTR), has been involved in a transaction dated 06/13/2024. Specific details regarding the nature of the transaction, including the number of shares, transaction price, and total value, have not been disclosed. The relationship of Loewy to the issuer was not specified in the announcement. Without these details, the impact of the transaction on Loewy's holdings and the overall market position of eFFECTOR Therapeutics remains unclear.
与eFFECTOR Therapeutics,Inc.(EFTR)相关的Caroline M. Loewy已参与了一项2024年6月13日的交易。交易的具体详情,包括股票数量、交易价格和总价值,未予披露。在公告中未指明Loewy与发行人的关系。没有这些细节,交易对Loewy的持股和eFFECTOR Therapeutics的整体市场地位的影响仍不清楚。
与eFFECTOR Therapeutics,Inc.(EFTR)相关的Caroline M. Loewy已参与了一项2024年6月13日的交易。交易的具体详情,包括股票数量、交易价格和总价值,未予披露。在公告中未指明Loewy与发行人的关系。没有这些细节,交易对Loewy的持股和eFFECTOR Therapeutics的整体市场地位的影响仍不清楚。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息